Open-label non-blinded cohort study on anti-histaminic resistant chronic idiopathic urticaria in Western India
Introduction: Chronic idiopathic urticaria (CIU) is a chronic relapsing disease with hives for a period of six weeks or more. It has a significant impact on the physical and mental well-being of patients. Aims and Objectives: Open-label non-blinded study of over 600 patients diagnosed with CIU was d...
Main Authors: | Subramanian Natarajan, Poonam Subramanian |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Indian Journal of Dermatology |
Subjects: | |
Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2022;volume=67;issue=5;spage=518;epage=523;aulast=Natarajan |
Similar Items
-
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
by: Anthony F. LaCava, et al.
Published: (2023-08-01) -
Clinical efficiency of cyclosporine in chronic idiopathic urticaria in adults
by: V.I. Petrov, et al.
Published: (2010-06-01) -
Consensus on the diagnostic and therapeutic management of chronic spontaneous urticaria in adults - Brazilian Society of Dermatology
by: Paulo Ricardo Criado, et al.
Published: (2019-06-01) -
Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?
by: Emek Kocatürk, et al.
Published: (2022-09-01) -
Turkey Urticaria Diagnosis and Treatment Guide based; Distribution of Chronic Urticaria Patients Treated in Our Clinic According to Step Therapy
by: Fatma Tuncez Akyurek, et al.
Published: (2021-01-01)